From a laboratory model to people.
Different research settings answer different questions. Progress is not guaranteed.
Learn how to read research, then look closely at the studies behind our stories.
Different research settings answer different questions. Progress is not guaranteed.
A useful result needs a useful comparison—not just a before-and-after change.
Keep the outcome, the denominator, the time period and the uncertainty together.
A decision about a defined product and use is not a universal endorsement of a molecule.
A close reading of the small human studies behind BPC-157 claims, and why laboratory promise is not clinical proof.
Why combining marketed peptides creates new questions about formulation, interactions and evidence instead of answering them.
Route, formulation and product quality change the question; evidence for one GHK-Cu preparation cannot be moved automatically to another.
A mechanism-level comparison of two growth-hormone-axis peptides, with the evidence and safety gaps kept separate from online stack claims.
What protein powders can add to resistance training, what the trials actually measure, and why a supplement is not a shortcut to muscle growth.
A practical way to read serving sizes, ingredient amounts, claims and quality signals without treating a label as proof of benefit.
What the strongest creatine evidence covers, which safety questions remain personal or product-specific, and why a common supplement still needs context.
What vitamin D does in the body, where supplementation helps prevent deficiency, and why broad prevention claims need trials that match the outcome.
A guide to the different semaglutide products, how they are taken and what they are approved for.
A mechanism-first explanation of GLP-1 and GIP, followed by the clinical questions a receptor story cannot answer on its own.
A practical guide to percentages, comparators, time points, missing data and why an average trial result is not a personal forecast.
Why a sunny windowsill, a hot car and a damp bathroom raise different product-specific questions.
How to interpret refrigeration, freezing and power-cut questions without assuming every product follows the same rule.
Understand labelled dates, opened products, packaging and why appearance alone cannot establish quality.
How to distinguish screening, airline conditions, product storage and destination law.
Plan for the actual product label, the complete journey, screening and delays.
Check the departure, transit and destination rules for the exact medicine, traveller and amount.
Official starting points for checking personal medicines, controlled substances and import requirements for Japan.
Official starting points for checking personal medicines, controlled substances and import requirements for Australia.
Official starting points for checking personal medicines, controlled substances and import requirements for Canada.
How to check personal medicines, controlled substances and border rules for the United Kingdom.
How to check personal medicines, controlled substances and border rules for the United States.
How to check personal medicines, controlled substances and border rules for Italy.
How to check personal medicines, controlled substances and border rules for Spain.
A comparison of specific 2026 US labels; the right instructions depend on the product and presentation.
What the 2026 US labels say for specific pens and vials, and why the presentations must be checked separately.
Official starting points for personal medicines, controlled substances and border rules for France.
Official starting points for personal medicines, controlled substances and border rules for Germany.
Official starting points for personal medicines, controlled substances and border rules for the United Arab Emirates.
Official starting points for personal medicines, controlled substances and border rules for Thailand.
Official starting points for personal medicines, controlled substances and border rules for Mexico.
How to read the label, understand live counts and respond to a temperature excursion.
How food, formulation and other medicines can change the answer, with examples of vitamin D, iron and calcium.
How to spot overlapping ingredients, prepare a useful list and ask about interactions.
Why a seller’s storage claim is not proof of stability, sterility or permission to travel.
The answer changes when a dry powder is mixed or a sealed drink is opened.
Sunlight, bathrooms, refrigeration and expiry dates depend on the product in the bottle.
How packaging, oxidation and the product label affect storage decisions.
What dry storage, moisture and mixing mean—and what experiments cannot tell you.
A beginner’s guide to oral, topical and injectable products.
A practical way to read the whole label and compare what you will actually consume.
Choline, essential fats, protein, fibre and water each have different roles—and a product is not the same thing as a nutrient.
What sodium and potassium do, where they come from, and when electrolyte products need more context.
Why semaglutide and tirzepatide matter for anaesthesia, and why the plan should be individual.
Planning pregnancy, unexpected exposure and why the reason for treatment matters.
What small cognitive studies, a pooled review and an EU scientific assessment actually found.
Sugar alcohols, added fibre and lactose are different possible explanations.
What the vitamins do, what trials measured, and why warfarin changes the question.
What semaglutide and tirzepatide trials reported, what might explain shedding, and why hair supplements are not an automatic answer.
How to understand purity, identity, strength, sterility and endotoxin claims—and what a seller’s document cannot tell you.
BPC-157, TB-500, CJC-1295 and other substances under the 2026 WADA list, plus medicines, exemptions and supplement risks.
What trials of Wegovy and Zepbound reported about gallstones and inflammation, and when to seek care.
Why thyroid medicine, mineral supplements and biotin blood-test claims need different explanations.
Why the answer depends on the exact medicine, formulation and length of the interruption.
What an early hormone study and a later hair-measurement trial can—and cannot—tell us.
What scans in semaglutide and tirzepatide studies show, and why lean mass is not the same as muscle strength.
What small clinical trials found, why mixtures are hard to interpret and what safety questions remain.
A 2026 pilot compared a supported psilocybin programme with nicotine patches. Here is what the result does—and does not—show.
Why product instructions differ, what was measured in a hormone study and when vomiting or diarrhoea matters.
What safety warnings, trial reviews and symptoms can—and cannot—tell us about semaglutide and tirzepatide.
How to interpret laboratory results, serving sizes and uncertainty without assuming every product is the same.
What placebo-controlled studies of psilocybin and LSD can—and cannot—tell us.
What a small controlled study found, and why a short-acting psychedelic is not yet a proven treatment.
What alertness, sleep, food, exercise and nutrient deficiencies can—and cannot—explain.
Separate attention, memory, fatigue and mood before asking whether a substance helps.
Understand medicines, food, movement and supplement claims without turning an average result into a personal forecast.
Look at timing, sleep quality, daytime effects and the evidence behind sleep-related products.
Understand everyday stress, anxiety and low mood; explore support, product claims and what clinical studies actually test.
Connect protein, creatine, training and function without treating a label claim as a performance result.
Find the difference between food, fibre, probiotics, symptoms and experimental claims about the gut.
Separate appearance, deficiency, cosmetic formulations and experimental repair claims.
Separate pain, mobility, injury recovery and laboratory repair claims.
Read longevity claims through function, disease outcomes, biomarkers and the limits of short studies.
Follow the different paths from animal foods and plants to the vitamin A your body uses.
Retinol, beta-carotene, RAE, IU and percentages explained with a worked label.
Why the form matters, how to read prenatal labels, and when a retinoid medicine needs urgent attention.
Why one medicine can reduce absorption while other products may increase the risk of excess.
Why one possible overdose and repeated high intake need different questions—and where to get help.
Why vitamin A matters in dim light, what else can affect sight and how deficiency is assessed.
What the two trials found, who they studied and why eye-supplement labels need a closer look.
ATBC and CARET tested supplements, not vegetables. Here is what they found and what the numbers mean.
Why children need vitamin A, why guidance differs and when a child needs medical help.
What differs between a vitamin supplement, a retinol serum and retinoid medicines—and what the studies show.
What the immune system needs, why deficiency matters and what infection studies can—and cannot—tell us.
Follow the different routes from a carrot or cod liver oil to the intestine, liver, eye and other tissues.
A practical comparison of skin serums, peptide blends and the claims behind them.
Understand local irritation, why causes can differ and when symptoms need prompt attention.
Why these peptides are discussed together, what each has been studied for and what remains unknown.
A practical guide to GHK-Cu on a skin-care label, its research and common questions.
Why the two peptides are discussed together, what their human studies measured and what remains uncertain.
Why semaglutide, tirzepatide, tesamorelin and AOD-9604 answer different questions.
What “fat-busting” claims can mean, what the body does naturally and which results matter.
A guide to the peptide, the older extract and the sleep-timing hormone—without treating them as the same thing.
The story behind the “fat-burning peptide” claim, from an older conference abstract to the OPTIONS study.
A close look at the people, scans and percentages behind a widely repeated abdominal-fat claim.
The SURMOUNT-1 substudy explains part of weight loss; it does not measure every aspect of muscle health.
Where abdominal fat is stored, how it is measured and what a number can—and cannot—say about health.
Follow the claim from an Achilles-tendon experiment in rats to the much smaller body of human evidence.
From cells in a dish to a small human skin study: how much does copper-peptide research tell us?
Follow the idea from intestinal cells and mouse studies to the separate question of injection-site reactions.
A practical guide to the shorter fragment, the longer molecule and the research often quoted for each.
The skin, hair and recovery ideas behind four peptide names—and what their separate studies actually tested.
A beginner’s guide to the signal, the hormone and why a blood-test change is not the same as a better outcome.
How a tanning peptide, cosmetic colour and related prescription medicines answer different questions.
A closer look at two small studies, the products they tested and what their results mean.
Local versus systemic claims, oral and topical products, and what route research can actually tell us.
From a small ulcerative-colitis trial to claims about capsules, the intestinal barrier and “gut healing”.
A molecule that responds to exercise is not automatically a substitute for it.
A related molecule, a small liver study and the difference between early results and proof.
A closer look at fatigue, muscle function, laboratory markers and the Barth-syndrome approval.
What fMRI can measure, what the two small studies reported and what they cannot tell us about focus or anxiety.
Acute stroke, later rehabilitation and the limits of two human reports.
Three small comparisons, what “similar” means and questions to take to a clinician.
Follow the claim from laboratory cells to a 15-year human study of a different preparation.
Why similar names can describe different substances—and what the human hormone studies actually tested.
Follow the human studies from early dry-eye results to larger trials and a different eye condition.
What withdrawal trials found, why people’s experiences differ and what to discuss before changing treatment.
How to interpret compatibility claims, product instructions and skin reactions without a one-size-fits-all rule.
Follow the “11 out of 12” claim back to the patients, the measurements and the missing comparison.
Follow the liver-fat measurement, the biopsy findings and the limits of a small trial.
Why a tanning peptide attracted sexual-health research, what the small studies found and how a related prescription medicine differs.
Practical food and fluid questions, from a smaller appetite to symptoms that need medical attention.
Why the scale can level off, what studies mean by a plateau and how to think about maintaining weight.
What the rabbit study measured, why hyaluronic acid appears in the claim and what remains unknown in people.
One peptide, one small molecule and a shared receptor: what the studies actually measured.
Three related signals, distinct products and different questions in the research.
A closer look at the questions, questionnaire scores, side effects and missing data behind the US prescription product.
What the rare eye warning means, which symptoms need urgent attention and how to interpret the evidence.
Why an eye warning in diabetes deserves attention, what SUSTAIN-6 measured and what remains uncertain.
Why the route matters, what human and animal studies measured, and what “stomach stable” does—and does not—mean.
Follow a peptide from a tablet to a possible effect, and see why one product cannot prove another will be absorbed.
A shared name, different molecules and different research questions.
Two studies, different comparisons and what a change in viral markers can actually tell us.
What immune support can mean, what everyday habits and vaccines do, and how to judge product claims.
Why one Italian medicine is used alongside vaccination, and what the small studies can tell us.
A large critical-care study, its corrected results and why its findings do not answer every immune-health question.
Follow the evidence and practical questions behind three very different ways this peptide is sold.
A practical look at pigmentation, serums, supplements and drips—without treating different studies as the same experiment.
A beginner’s guide to common causes, sun protection and deciding when a changing spot needs attention.
Why a treatment for an area under the chin, an appetite medicine and a peptide marketed for fat loss answer different questions.
Follow the difference between a nerve image, a symptom score and evidence that a treatment improves daily life.
A plain-language guide to possible causes, clinical checks and what different tests can—and cannot—show.
Why deficiency and supplement excess can cause similar symptoms, and what to take to a healthcare appointment.
Why tingling or weakness after laughing gas deserves attention, even when a B12 result looks normal.
Why a blood number is one part of the story, and why symptoms, supplements and the reason for testing matter.
A laboratory trust game, a replication and clinical trials answer different questions. Here is how to read them.
Follow two studies beyond six months and see what their measurements can—and cannot—predict.
A practical guide to the signals, side effects and uncertainties in US Egrifta WR information.
What a reaction can mean, when to seek help and how to make sense of the products involved.
Understand the tissue, the symptoms and why recovery is more than a pain score.
From a blood test in healthy volunteers to a small Achilles study: what did researchers actually measure?
A dated guide to the HHS policy, multi-ingredient blends and a separate planned FDA advisory discussion.
Selected historical examples, not a comprehensive evidence review.
A historical case study in reading populations, endpoints and comparisons.
Why a short-term result and a lasting benefit are not the same conclusion.
Read the study setting, the outcome and the limitation alongside the claim. Our proposed evidence standards →